Client Becomes Director of Research at Braverman Reproductive Immunology
Darren Ritsick, Ph.D., came to Braverman Reproductive Immunology after he and his wife struggled with recurrent pregnancy loss for more than two years. Today, Braverman Reproductive Immunology is ready to welcome Dr. Ritsick onto its team as its new Director of Research.
New York, NY, (PRWEB) January 15, 2013
Braverman Reproductive Immunology is pleased to welcome a new Director of Research to its professional team: Darren Ritsick, Ph.D. A short time ago, Dr. Ritsick and his wife, Maggie, came to Dr. Braverman seeking a solution to their two-year struggle with recurrent pregnancy loss. During the course of the couples' treatment, Dr. Braverman learned that Dr. Ritsick possessed the same passion for helping others that Braverman Reproductive Immunology exemplifies. Today, Dr. Ritsick is ready to join the team of professionals at Dr. Braverman's office as Director of Research. Because of the treatment provided by the Dr. Braverman, he and his wife are expecting a son.
Dr. Ritsick possesses an impressive understanding of reproductive immunology. Additionally, he is able to empathize with clients and understands the specific pain and frustration associated with recurrent pregnancy loss. He graduated with honors and a Bachelor of Science in Biology from the University of Richmond. As an undergraduate student, he began researching the genetic basis of developing brain tumors. He also worked as an intern at the Center for Immunotherapy of Cancer and Infection Diseases at the University of Connecticut Health Sciences Center. After graduation, he decided to further his education at Emory University.
As a graduate student, Dr. Ritsick worked towards a Ph.D. in Biochemistry, Cell and Developmental Biology at the university. There, he began working on research on novel biological roles for reactive oxygen species. During this time, he gained a valuable understanding of genetics, biochemistry, cell biology and molecular biology. The National Institutes of Health supported a portion of his doctoral work through a training grant, which resulted in presentations at several large scientific conferences and six publications in peer-reviewed journals. Today, Dr. Ritsick is ready to use his interdisciplinary educational background to help clients at Braverman Reproductive Immunology.
After graduation, Dr. Ritsick worked as a Scientific Advisor for a patent law firm, participating in a various stages of the patent prosecution process. Specifically, he helped handle cases that involved biotechnology and pharmaceuticals. During this time, he had the opportunity to work with a diverse client bases that involved universities, biotechnology companies and large pharmaceutical companies. A substantial portion of his work involved autoimmune disease and cancer treatment development. Before working with Braverman Reproductive Immunology, Dr. Ritsick worked in the Department of Neurosurgery as Senior Research Project Coordinator at Emory University. Additionally, he worked at Winship Cancer Institute as coordinator for the Cancer Cell Biology Program.
Since its inception, Braverman Reproductive Immunology has worked to help couples make their dreams of starting or expanding their families a reality. Dr. Braverman is experienced in in vitro fertilization (IFV), frozen embryo transfers (FET) and other issues related to pregnancy and recurrent pregnancy loss. Braverman Reproductive Immunology has an impressive record of success. In fact, 100% of their donor egg cycle patients have been able to conceive. Together, Dr. Braverman and Dr. Ritsick will continue to help clients work through recurrent pregnancy loss problems and begin families by offering them the best medical and scientific assistance, advice and treatment they give. Braverman Reproductive Immunology is committed to achieving the highest standard of professional excellence and continues help couples who would otherwise not be able to conceive. To learn more about Braverman Reproductive Immunology, visit http://www.preventmiscarriage.com.
For the original version on PRWeb visit: http://www.prweb.com/releases/prweb2013/1/prweb10328038.htmView Comments and Join the Discussion!